Glenmark’s bi-apecific antibody – GBR 1302 to enter Phase I trials
Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year
Glenmark…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.